Francesco Cavallieri

@ausl.re.it

Neuromotor and rehabilitation deparment
AUSL - IRCCS of Reggio Emilia

I’m a medical doctor specialized in Neurology with a PhD degree in Clinical and Experimental medicine and I am currently working as a Neurologist at the Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Since the beginning of my studies in Medicine I was appealed by the complex structure and the amazing potentials of the human brain. This passion has been increasing since I attended Neurology and Neurophysiology classes, which allowed me to understand the anatomical and physiological basis of the nervous system and the physiopathology of the major neurological diseases. During the residency training program, I have been developing a strong interest in clinical research focused on Movement Disorders, with particular regard for advanced therapies in Movement Disorders like Subthalamic Nucleus (STN) and Globus Pallidus (GPI) Deep Brain Stimulation (DBS); subcutaneous and intrajejunal pumps for continuous drug infusion and bot

EDUCATION

2012 MD
University of Modena and Reggio Emilia, Modena, Italy
2018 Board Certification in Neurology
University of Modena and Reggio Emilia, Modena, Italy
2022 PhD degree in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Italy.

RESEARCH, TEACHING, or OTHER INTERESTS

Neurology (clinical)
146

Scopus Publications

Scopus Publications

  • The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancer
    Valentina Fantini, Giulia Di Rauso, Valentina Fioravanti, Alessia Ciarrocchi, Francesco Cavallieri, Valentina Sancisi
    Cell Death Discovery, 2026
    The GBA1 gene encodes the enzyme glucocerebrosidase, which is responsible for lysosomal degradation of the glycosphingolipid glucosylceramide. Biallelic mutations in GBA1 are causative for Gaucher disease, whereas either monoallelic or biallelic mutations are a risk factor for Parkinson’s disease. GBA1 mutations, beside reducing enzymatic activity and leading to substrate accumulation, influence a number of molecular and cellular pathways, including lipid homeostasis, endosome-lysosome pathway, endoplasmic reticulum to Golgi protein trafficking, autophagy and mitophagy. Given the critical role of GBA1 in these key pathways for cellular homeostasis, it can be expected that alterations in this enzyme may influence also cancer development and/or pathology, keeping in mind that Gaucher disease is associated with an increased risk of cancer development. Notably, a large fraction of patients affected by different cancer types carry an amplification of the long arm of chromosome 1, that includes the GBA1 gene. Furthermore, GBA1 expression is elevated in different cancer tissues, compared with healthy counterparts and associated with outcome in some cases. In this perspective, we narratively review the main evidence supporting a role for GBA1 in influencing tumorigenesis and we present our analyses on GBA1 amplification and expression throughout different cancer types. Taken together, these data suggest that the presence of a GBA1 germline mutation or a somatic amplification may influence cancer pathogenesis and/or response to therapies through context-dependent mechanisms that are still to be characterized.
  • Breaking the PERM pattern: glycine receptor antibody-related myoclonic syndrome
    Giulia Di Rauso, Giacomo Portaro, Valentina Fioravanti, Luca Codeluppi, Ilaria Martinelli, Fortuna Ricciardiello, Maria Lucia Valentino, Franco Valzania, Sara Montepietra, Maria Pia Giannoccaro, Francesco Cavallieri
    Parkinsonism and Related Disorders, 2026
  • Loss of serotonergic function in carriers of PRKN mutations: a [11C]DASB PET study
    Edoardo Rosario de Natale, Heather Wilson, Joji P. Verghese, Eoin Mulroy, Savvas Antoniadis, Alana Terry, Francesco Cavallieri, Micol Avenali, Pasquale Nigro, Varvara Valotassiou, Eugenii A. Rabiner, Stephen Mullin, Nicola Tambasco, Maria Teresa Pellecchia, Georgia Xiromerisiou, Vicky L. Marshall, Esther Sammler, Enza Maria Valente, Franco Valzania, Kailash P. Bhatia, Marios Politis
    European Journal of Nuclear Medicine and Molecular Imaging, 2026
    We investigated serotonergic and dopaminergic terminal integrity role in PRKN-associated Parkinsonism (PRKN-PD) using [¹¹C]DASB Positron Emission Tomography (PET) and [¹²³I]FP-CIT Single Photon Emission Computerised Tomography (SPECT). Fourteen PRKN-PD patients (mean age 49.70 ± 10.83, disease duration 10.95 ± 7.59 years, H&Y 2.0 ± 0.68), and twelve iPD patients (mean age 65.40 ± 7.48 years, disease duration 5.05 ± 4.50 years, H&Y 2.0 ± 0.93) underwent clinical assessments, 3-Tesla MRI, [11C]DASB PET-CT, and [123I]FP-CIT SPECT, and compared with previously acquired healthy control (HCs) data. [11C]DASB distribution volume ratio (DVR) parametric images were generated and DVR-1 values, equivalent to BPND, sampled from a priori selected regions-of-interest (ROIs) with the posterior cerebellum as reference. [123I]FP-CIT images underwent reconstruction and normalization to standard space, and striatal Specific Binding Ratio (SBR) calculated from the eight hottest consecutive slices. PRKN-PD patients showed 20.8% to 45.2% [11C]DASB BPND loss across several cortical and subcortical ROIs compared to HCs (p ≤ 0.01). After adjusting for age and disease duration, no differences in [11C]DASB BPND were observed between PRKN-PD and iPD. In PRKN-PD, higher [11C]DASB BPND in the raphe, brainstem, ventral striatum, and amygdala, correlated with higher scores on the Non-Motor Symptoms Scale (p < 0.05). Higher [11C]DASB BPND in the caudate and putamen correlated with higher scores on the Beck Depression Inventory II scale (p < 0.05). No correlation was detected between [11C]DASB BPND and [123I]FP-CIT SBR in the caudate and putamen. PRKN-PD is characterized by widespread serotonergic dysfunction, which is independent of dopaminergic degeneration and linked to key non-motor symptoms, particularly depression. These findings provide novel insights into the pathophysiology of PRKN-PD.
  • Bell’s palsy as the first manifestation of neurosyphilis in an immunocompetent and HIV-negative patient: a challenging diagnosis
    Marco Bisquoli, Massimo Bondavalli, Claudia Lazzaretti, Manuela Napoli, Letizia Caprari, Pedro Fraiman, Sergio Mezzadri, Sara Montepietra, Francesco Cavallieri
    Neurological Sciences, 2026
  • The use of single-point magneto-inertial measurement for gait and dynamic balance assessment of patients with Parkinson’s disease and Parkinsonisms: a systematic review with critical appraisal of clinical applications and quality of reporting
    Lorenzo Cavazzuti, Benedetta Damiano, Andrea Merlo, Maria Chiara Bò, Sara Scaltriti, Francesco Cavallieri, Giulia Di Rauso, Giacomo Portaro, Giacomo Argenziano, Valentina Fioravanti, Isabella Campanini
    Frontiers in Neurology, 2026
    Introduction Gait and balance impairments are among the most disabling motor symptoms of Parkinson’s disease (PD) and parkinsonisms. Traditional clinical assessments are practical but often lack sensitivity to detect subtle functional changes and to monitor disease progression. Wearable magneto-inertial measurement units (mIMUs) offer an objective, portable, and low-cost alternative. Single-point mIMUs, positioned over the lower trunk, are particularly promising for clinical integration due to their simplicity. This systematic review critically evaluates how single-point mIMUs are used to assess functional mobility in PD and atypical parkinsonisms, and examines the quality and clinical transferability of current evidence. Methods Following PRISMA 2020 guidelines, a systematic search was conducted in Medline, CINAHL, Embase, and Scopus (January 2025). Eligible studies included adults with PD or atypical parkinsonisms assessed with a single wearable sensor during straight-line walking and/or the Timed Up and Go test. Data extraction included clinical characteristics, assessment protocols, sensor specifications, and computed parameters. A customized critical appraisal tool evaluated five domains: methodology, clinical aspects, assessment protocol, technical aspects, and clinical transferability. Studies were classified as high-, medium-, or low-quality. Results From 3,812 records, 41 studies met inclusion criteria, involving 395 participants (mean age 66 ± 5.9 years). Fourteen studies used the instrumented TUG, and 27 evaluated straight-line walking. Most studies were observational (90%). Only 12% achieved a high-quality rating, while 80% were medium-quality. “Technical aspects” was the best-rated domain, whereas “clinical aspects” and “assessment protocol” scored lowest, mainly due to incomplete reporting of sensor placement, acquisition conditions, computational methods, and clinical characterization of participants. Frequently reported outcomes included gait speed, step length, cadence, and TUG duration; however, methodological heterogeneity hindered cross-study comparability. Discussion Single-point mIMUs can detect clinically relevant gait and mobility impairments and hold potential for monitoring disease progression, evaluating treatment effects, and distinguishing patient subgroups. Nevertheless, the overall quality of evidence is moderate, and insufficient methodological transparency currently limits clinical translation. Standardization of sensor placement, task instructions, data processing, and reporting—along with clearer clinical rationale and sample characterization—is needed to support reproducibility and facilitate adoption in routine practice. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251025333 .
  • Artificial Intelligence Predicts GBA1 Mutated Status in Parkinson's Disease Patients
    Giulia Di Rauso, Alessandro Ghibellini, Sara Grisanti, Valentina Fioravanti, Edoardo Monfrini, Giulia Toschi, Giacomo Portaro, Giacomo Argenziano, Ruggero Bacchin, Jessica Rossi, Rossella Sabadini, Valeria Ferrari, Andrea Melpignano, Francesca Pacillo, Maria Scarano, Anna Groppi, Luca Gherardini, Chiara Lucchi, Giuseppe Biagini, Sara Montepietra, Maria Chiara Malaguti, Isabella Campanini, Andrea Merlo, Andrea Castellucci, Angelo Ghidini, Alessandro Fraternali, Annibale Versari, Augusto Scaglioni, Jefri J. Paul, Luciano Bononi, Maurizio Gabbrielli, Alessio Di Fonzo, Peter Bauer, Francesco Cavallieri, Franco Valzania
    Movement Disorders Clinical Practice, 2026
    Background GBA1 variants are the major genetic risk factor for Parkinson's Disease (PD) and account for 5–30% of PD cases depending on the population and age at onset of the disease. Objectives The aim of this study was to assess whether Artificial Intelligence (AI) could predict GBA1 ‐mutated genotype in PD ( GBA1 ‐PD). Particularly, the main objective was to identify a Machine Learning (ML) model capable of accurately providing a pre‐test estimate of GBA1 ‐mutated status, relying on the clinical and demographic variables with the highest predictive value. Methods A cohort of GBA1 ‐PD patients has been paired with non‐mutated PD (NM‐PD). The dataset comprised 58 GBA1 ‐PD and 58 NM‐PD, for each of whom 124 features were recorded. A Leave‐One‐Out cross‐validation method was employed for testing and SHapley Additive exPlanations (SHAP) for examine each feature's contribution. XGBoost resulted the most effective ML model for this supervised classification task. Results Through AI, we developed a model based on four specific clinical features with significant impact in predicting GBA1 ‐mutated genotype with an accuracy of 73%, reaching 94% in a subset of patients where the model has a SHAP confidence level greater than 80%. These variables included family history and scores for cognitive (MDS‐UPDRS 1.1) and motor impairment (MDS‐UPDRS 3.8a and 3.8b and rigidity subscore). Conclusions This study underlies the potential of AI in enhancing targeted genetic screening in PD, especially in clinical settings where resources are limited. Main limitations of this study are the modest sample size and lack of external validation. Further studies on larger, independent cohorts are needed to refine the predictive model.
  • Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease
    Massimo Marano, Carmela Zizzo, Francesco Cavallieri, Micol Avenali, Tommaso Schirinzi, Edoardo Monfrini, Francesca Spagnolo, Rosa De Micco, Silvia Ramat, Maria Chiara Malaguti, Federico Reali, Roberto Cilia, Miryam Carecchio, Andrea Pilotto, Roberto Erro, Ilaria Antonella di Vico, Mario Meloni, Giulia Di Lazzaro, Sara Pietracupa, Claudia Ledda, Giovanni Mostile, Marcello Mario Mascia, Valentina Fioravanti, Giulia di Rauso, Roberta Bovenzi, Simone Aloisio, Marco Liccari, Ruggero Bacchin, Fabiana Colucci, Giulia Bonato, Alessandro Lupini, Alessandro Magliozzi, Cristiano Sorrentino, Francesca Leo, Giulia Franco, Nicola Modugno, Maurizio Zibetti, Gennarina Arabia, Anna Rita Bentivoglio, Elena Caputo, Filippo Tamma, Alessandro Padovani, Mario Zappia, Roberto Eleopra, Michele Tinazzi, Giovanni Fabbrini, Alessandro Tessitore, Vincenzo Di Lazzaro, Enza Maria Valente, Giovanni Duro, Alessio Di Fonzo
    Neurobiology of Disease, 2026
    BACKGROUND: GBA1 mutation is the most significant genetic risk factor for Parkinson's disease (PD). It encodes glucocerebrosidase (GCase), whose dysfunction - seen in Gaucher disease - leads to the accumulation of glucosylceramide and its derivate glucosylsphingosine (GlcSph). However, it remains unclear whether GCase and GlcSph are relevant in PD patients carrying no or monoallelic GBA1 variants, and what their clinical impact might be. OBJECTIVE: Investigating the relationships between GBA1 mutations, GCase, GlcSph, and clinical features in a large PD cohort. METHODS: We performed a cross-sectional study of PD patients screened for GBA1 mutations, GCase activity, and GlcSph via dried blood spot tests. Patients were classified as heterozygous mutation carriers (GBA1-PD) or non-carriers (nonGBA1-PD). Collected data included motor and non-motor parameters. Molecular and clinical differences were compared between GBA1-PD and nonGBA1-PD. Distinctive clinical features were further investigated through multivariate models to test their correlations with biochemical data. RESULTS: The cohort included 611 subjects (225 GBA1-PD, 386 nonGBA1-PD). GBA1-PD presented earlier onset, lower cognitive scores, higher incidence of mood disturbances and more advanced stage. Motor assessment revealed a higher frequency and severity of dyskinesias, independently from disease duration and LEDD. GlcSph levels showed an independent correlation with dyskinesia severity and time at onset in GBA1-PD patients, which was independent of sex, LEDD, UPDRS-III, disease duration and GBA1 mutation class. CONCLUSIONS: This study reveals an association between GlcSph and dyskinesias in GBA1-PD, that should prompt further investigation to assess the GlcSph role as a possible biomarker and target to tackle dyskinesias in GBA1-PD.
  • The Criss-Cross Gait Is Not Child's Play
    Susanna Rizzi, Carlo Alberto Cesaroni, Daniele Frattini, Agnese Pantani, Francesco Cavallieri, Sara Montepietra, Carlo Fusco
    Movement Disorders Clinical Practice, 2026
    Ethical Compliance Statement: The authors confirm that the approval of an institutional review board was not required for this work. The informed consent was obtained from the patient's parents. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Funding Sources and Conflicts of Interest: No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work. Financial Disclosures for the Previous 12 Months: The authors declare that there are no additional disclosures to report. The data that support the findings of this study are available from the corresponding author upon reasonable request. TABLE S1. Clinical, genetic, and metabolic features of individuals with Glut1 deficiency who exhibit a specific criss-cross gait pattern. ID: intellectual disability, PED: paroxysmal exercise-induced dyskinesia, PKD: paroxysmal kinesigenic dyskinesia, PNKD: paroxysmal non kinesigenic dyskinesia, PMD: paroxysmal movement disorder, NA: not available. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
  • Citalopram-Induced Tongue Dyskinesia
    Davide Fontanesi, Francesco Cavallieri, Anna Groppi, Annalisa Gessani, Giulia Di Rauso, Sara Montepietra, Valentina Fioravanti, Franco Valzania
    Canadian Journal of Neurological Sciences, 2026
  • RAB3A variants in ataxia and other neurodegenerative disorders
    Marco Percetti, Edoardo Monfrini, Roberto Del Bo, Margherita Canesi, Francesco Cavallieri, Giulia Di Rauso, Valentina Fioravanti, Eleonora Del Prete, Daniela Frosini, Giovanni Palermo, Roberto Ceravolo, Giorgio Sacilotto, Alessio Di Fonzo
    Brain, 2026
  • Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases
    Giacomo Portaro, Michelangelo Giacomelli, Sara Grisanti, Lisa Taruffi, Giulia Di Rauso, Valentina Fioravanti, Gaetano Salomone, Giacomo Argenziano, Rossella Sabadini, Giulia Toschi, Ottavia Iotti, Isabella Campanini, Andrea Merlo, Lorenzo Cavazzuti, Benedetta Damiano, Sara Scaltriti, Augusto Scaglioni, Jefri J. Paul, Peter Bauer, Giuseppe Biagini, Edoardo Monfrini, Alessio Di Fonzo, Sara Montepietra, Franco Valzania, Marco Vecchi, Francesco Cavallieri
    Parkinsonism and Related Disorders, 2026
  • Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals
    Elisa Menozzi, Yani Ren, Mallia Geiger, Jane Macnaughtan, Micol Avenali, Marco Toffoli, Marine Gilles, Rosaria Calabrese, Pierfrancesco Mitrotti, Luca Gallo, Alexandre Famechon, Sara Lucas Del Pozo, Roxana Mezabrovschi, Sofia Koletsi, Nadine Loefflad, Selen Yalkic, Naomi Limbachiya, Frederick Clasen, Suleyman Yildirim, Saeed Shoaie, Hervé Blottière, Christian Morabito, Aymeric David, Benoit Quinquis, Nicolas Pons, Emmanuelle Le Chatelier, Franco Valzania, Francesco Cavallieri, Valentina Fioravanti, Giulia Toschi, Fabio Blandini, Mathieu Almeida, Stanislav Dusko Ehrlich, Victoria Meslier, Anthony H. V. Schapira
    Nature Medicine, 2026
  • Instrumental evaluation of the effect of oral medium-chain triglycerides oil on paroxysmal exercise‐induced dyskinesia in GLUT1 deficiency syndrome
    Zeno Bercini, Francesco Cavallieri, Isabella Campanini, Lorenzo Cavazzuti, Sara Scaltriti, Benedetta Damiano, Annalisa Gessani, Jessica Rossi, Sara Montepietra, Franco Valzania, Andrea Merlo
    Neurological Sciences, 2025
  • Resting and action tremor in Parkinson’s disease: pathophysiological insights from long-term STN-DBS
    Alessandro Zampogna, Antonio Suppa, Martina Patera, Francesco Cavallieri, Francesco Bove, Valerie Fraix, Anna Castrioto, Emmanuelle Schmitt, Pierre Pelissier, Stephan Chabardes, Sara Meoni, Elena Moro
    Npj Parkinson S Disease, 2025
  • Severe GBA1 variants drive the GBA1-PD clinical phenotype: implications for counselling and clinical trials
    Elisa Menozzi, Sara Lucas Del Pozo, Jane Macnaughtan, Roxana Mezabrovschi, Sofia Koletsi, Pierfrancesco Mitrotti, Luca Gallo, Rosaria Calabrese, Marco Toffoli, Nadine Loefflad, Franco Valzania, Francesco Cavallieri, Valentina Fioravanti, Selen Yalkic, Naomi Limbachiya, Fabio Blandini, Micol Avenali, Anthony HV Schapira
    Npj Parkinson S Disease, 2025
  • Compound Heterozygous Structural Variants in Cases with Unsolved PRKN-Associated Parkinson's Disease
    Agata Fant, Sara Trova, Edoardo Monfrini, Gaia Treves, Francesco Musacchia, Fabio Landuzzi, Paola Mandich, Antonio Amoroso, Remo Sanges, Luca Pandolfini, Francesco Cavallieri, Franco Valzania, Valentina Fioravanti, Giulia Di Rauso, Gloria Brescia, Enza Maria Valente, Valeria Tiranti, Luigi Michele Romito, Chiara Reale, Barbara Garavaglia, Antonio Emanuele Elia, Andrea Cavalli, Alessio Di Fonzo, Manuela Vecchi, Stefano Gustincich
    Movement Disorders, 2025
  • RAB32-Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria
    Teresa Kleinz, Francesco Cavallieri, Max Borsche, Giulia Toschi, Franco Valzania, Valentina Fioravanti, Enza Maria Valente, Pierfrancesco Mitrotti, Micol Avenali, Simone Zittel, Rommi Born, Michele Matarazzo, Alessio Di Fonzo, Edoardo Monfrini, Mandy Radefeldt, Letizia Santinelli, Norman Griebner, Cholpon Shambetova, Max Brand, Carolin Gabbert, Cornelis Blauwendraat, Joanne Trinh, Katja Lohmann, Christian Beetz, Peter Bauer, Norbert Brüggemann,, Christine Klein
    Movement Disorders, 2025
  • Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation
    Francesco Bove, Danilo Genovese, Alessandro De Biase, Alberto Albanese, Angelo Antonini, Carlo Alberto Artusi, Laura Avanzino, Micol Avenali, Luca Baldelli, Giovanna Calandra-Buonaura, Ilaria Cani, Niccolò Casasoli, Francesco Cavallieri, Roberto Cilia, Antoniangela Cocco, Fabiana Colucci, Francesca Di Biasio, Valentina D’Onofrio, Roberto Eleopra, Valentina Fioravanti, Giulia Giannini, Nico Golfre’ Andreasi, Andrea Guerra, Gabriele Imbalzano, Alessandro Izzo, Claudia Ledda, Marco Liccari, Leonardo Lopiano, Maria Chiara Malaguti, Raffaella Minardi, Pierfrancesco Mitrotti, Luigi Michele Romito, Enza Maria Valente, Franco Valzania, Roberta Zangaglia, Paolo Calabresi, Carla Piano, Anna Rita Bentivoglio, , C. Caltagirone, A. Costa, F. R. Giardina, A. Peppe, C. Pellicano, F. E. Pontieri, F. Piras, F. Sommaruga, G. Sancesario, S. Zabberoni, R. Cilia, F. De Giorgi, G. Devigili, R. Eleopra, A. Elia, B. Garavaglia, G. Giaccone, M. Grisoli, V. Leta, F. Moda, B. Reggiori, L. M. Romito, I. Tramacere, S. Piacentini, M. Avenali, R. Bergamaschi, R. Calabrese, S. Cerri, G. Cosentino, G. Cuconato, R. De Icco, C. Galandra, A. Imarisio, P. Mitrotti, C. Pacchetti, I. Palmieri, M. Picascia, A. Pichiecchio, A. Pisani, C. Tassorelli, E. M. Valente, F. Valentino, R. Zangaglia, C. Agliardi, F. Baglio, A. Caronni, F. Guerini, R. Mancuso, A. Mannini, M. Meloni, F. Saibene, S. Sorbi, F. Vannetti, A. Ciammola, L. Maderna, B. Poletti, A. Ratti, V. Silani, N. Ticozzi, F. Triulzi, F. Verde, G. Zebellin, F. Agosta, S. Amadio, V. Broccoli, R. Cardamone, M. Filippi, S. Galantucci, L. Gianolli, M. Morelli, E. Sarasso, J. Sassone, M. R. Terreni, M. A. Volontè, R. Bellazzi, E. Brigonzi, M. Buonocore, R. Campini, F. Cossa, E. Federici, M. Gennuso, E. Losavio, A. Losurdo, C. Lunetta, G. Maggioni, A. Malovini, C. Morasso, M. Nolano, E. Parati, C. Pistarini, D. M. Rossi, M. Terzaghi, V. Tibollo, L. Avanzino, G. Bonanno, L. Boni, C. Campi, E. Capello, G. Ferrara, A. Gaudio, G. Lagravinese, P. Mandich, R. Marchese, F. Massa, S. Morbelli, F. Nobili, P. Origone, E. Pelosin, L. Roccatagliata, L. Trevisan, A. Arcella, G. Battaglia, D. Belvisi, A. Berardelli, D. Centonze, R. Ferese, S. Gambardella, A. Gialluisi, F. Giangaspero, C. Limatola, N. Modugno, P. Pantano, L. Pavone, S. Puglisi Allegra, A. Brigandì, G. Di Lorenzo, V. Lo Buono, S. Marino, S. Silvestro, C. Sorbera, S. Bonassi, F. Brancati, M. F. De Pandis, B. Picconi, P. M. Rossini, F. Stocchi, L. Vacca, A. Albanese, L. Antunovic, A. Cocco, T. De Santis, R. Gatti, S. Lalli, E. Lauranzano, M. Matteoli, R. Mineri, E. Paraboschi, E. Perdixi, L. Politi, P. Polverino, D. Pozzi, G. Savini, A. R. Bentivoglio, F. Bove, P. Calabresi, A. Cimmino, A. De Biase, G. Di Lazzaro, D. Di Giuda, D. Genovese, M. R. Lo Monaco, M. Petracca, C. Piano, F. D. Tiziano, M. G. Vita, G. Arcara, R. Barresi, V. Camparini, P. Cudia, G. Ferrazzi, K. Koutsikos, N. Manzo, F. Pellizzari, A. Arighi, F. Blandini, F. Cogiamanian, M. Castellani, F. Colucci, M. Cribiù, A. Di Fonzo, G. Franco, E. Frattini, C. Losa, F. Mameli, E. Monfrini, E. Scola, I. Trezzi, M. G. Bacalini, L. Baldelli, G. Calandra-Buonaura, I. Cani, L. Caporali, V. Carelli, P. Cortelli, P. Ghedini, P. Guaraldi, G. Giannini, G. Lopane, R. Minardi, A. Fiorentino, F. Nonino, R. Pantieri, P. Parchi, F. Provini, C. Tonon, L. Sambati
    Npj Parkinson S Disease, 2025
  • Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant
    Micol Avenali, Carlo Alberto Artusi, Roberto Cilia, Giulia Giannini, Giada Cuconato, Alberto Albanese, Nico Golfrè Andreasi, Pietro Antenucci, Angelo Antonini, Laura Avanzino, Luca Baldelli, Anna Rita Bentivoglio, Francesco Bove, Marco Bozzali, Giovanna Calandra-Buonaura, Ilaria Cani, Valerio Carelli, Francesco Cavallieri, Antoniangela Cocco, Filippo Cogiamanian, Fabiana Colucci, Pietro Cortelli, Alesssandro De Biase, Francesca Di Biasio, Alessio Di Fonzo, Valentina D'Onofrio, Roberto Eleopra, Antonio Emanuele Elia, Valentina Fioravanti, Danilo Genovese, Andrea Guerra, Alberto Imarisio, Claudia Ledda, Marco Liccari, Chiara Longo, Leonardo Lopiano, Maria Chiara Malaguti, Rachele Malito, Francesca Mameli, Silvia Marino, Raffaella Minardi, Pierfrancesco Mitrotti, Edoardo Monfrini, Claudio Pacchetti, Carla Piano, Vittorio Rispoli, Mario Giorgio Rizzone, Luigi Michele Romito, Luisa Sambati, Mariachiara Sensi, Chiara Sorbera, Francesca Spagnolo, Cristina Tassorelli, Francesca Valentino, Franco Valzania, Roberta Zangaglia, Maurizio Zibetti, , Enza Maria Valente, Valentina Leta, Sylvie Piacentini, Ilaria Palmieri, Marta Picascia, Stefania Lalli, Paola Polverino, Paola Mandich, Roberta Marchese, Giuseppe Di Lorenzo, Amelia Brigandi, Giulia Di Lazzaro, Martina Petracca, Ilaria Trezzi, Emanuele Frattini, Alessia Fiorentino, Pietro Guaraldi
    Neurology, 2025
  • Clinical predictors of speech changes after subthalamic neurostimulation in Parkinson’s disease
    Francesco Cavallieri, Francesco Bove, Alessandro Zampogna, Anna Castrioto, Sara Meoni, Annalisa Gessani, Emmanuelle Schmitt, Pierre Pélissier, Franco Valzania, Antonio Suppa, Serge Pinto, Stephan Chabardès, Valerie Fraix, Elena Moro
    Neurological Sciences, 2025
  • Digital Inclusion in Parkinson's Disease: A Case–Control Study
    Vincenzo Canoro, Andrea Pilotto, Francesco Lena, Valentina Fioravanti, Chiara Longo, Tommaso Schirinzi, Marina Picillo, Maria Teresa Pellecchia, Cristiano Sorrentino, Francesco Cavallieri, Alessandro Padovani, Maria Chiara Malaguti, Nicola Modugno, Paolo Barone, Roberto Erro
    Movement Disorders Clinical Practice, 2025
  • Surface Dynamic Gait EMG Assessment of Paroxysmal Muscle Spasm in Stiff-Person Syndrome
    Francesco Cavallieri, Lorenzo Cavazzuti, Benedetta Damiano, Giacomo Portaro, Sara Scaltriti, Sara Montepietra, Valentina Fioravanti, Giulia Di Rauso, Andrea Merlo, Isabella Campanini, Franco Valzania
    Movement Disorders Clinical Practice, 2025
  • Dopa responsive dystonia due to a GCH1 gene variant mimicking hereditary spastic paraparesis
    D. Fontanesi, Giulia Di Rauso, F. Cavallieri, V. Fioravanti, E. Monfrini, J. Rossi, G. Toschi, R. Sabadini, S. Montepietra, A. Merlo, I. Campanini, L. Cavazzuti, A. Di Fonzo, F. Valzania
    Neurological Sciences, 2025
  • Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, “Real-World” Study. The EPIC Study
    Roberto Cilia, Fabiana Colucci, Emanuele Cereda, Antonio E. Elia, Valentina Leta, Silvia Barca, Maurizio Zibetti, Miryam Carecchio, Salvatore Bonvegna, Giovanna Calandra‐Buonaura, Rocco Cerroni, Rosa De Micco, Stefano Tamburin, Luca Magistrelli, Francesco Lena, Marcello M. Mascia, Marina Picillo, Giovanni Cossu, Massimo Marano, Alessandro Zampogna, Clelia Pellicano, Valentina Fioravanti, Andrea Pilotto, Roberta Zangaglia, Micol Avenali, Chiara Sorbera, Francesca Di Biasio, Federica Arienti, Alessandra Nicoletti, Caterina Bagella, Maria Chiara Malaguti, Alessandra Ranghetti, Elena Caputo, Dario Alimonti, Elena Torre, Gaia D. Oggioni, Catia Leuzzi, Luigi M. Romito, Nico Golfrè Andreasi, Grazia Devigili, Roberta Telese, Arianna Braccia, Gianfranco Gaudiano, Samanta Mazzetti, Federica Invernizzi, Barbara Garavaglia, Gabriele Imbalzano, Claudia Ledda, Pietro Antenucci, Andrea Gozzi, Giulia Bonato, Marco Percetti, Giulia Giannini, Luisa Sambati, Tommaso Schirinzi, Martina D'Anna, Domiziana Rinaldi, Francesco Cavallieri, Marco Liccari, Alberto Priori, Maria Sessa, Filippo Tamma, Margherita Canesi, Paolo Solla, Mario Zappia, Alessio Di Fonzo, Laura Avanzino, Angelo Quartarone, Enza Maria Valente, Claudio Pacchetti, Alessandro Padovani, Franco Valzania, Francesco E. Pontieri, Antonio Suppa, Maria Teresa Pellecchia, Nicola Modugno, Cristoforo Comi, Michele Tinazzi, Alessandro Tessitore, Alessandro Stefani, Pietro Cortelli, Ioannis U. Isaias, Angelo Antonini, Mariachiara Sensi, Leonardo Lopiano, Roberto Eleopra
    European Journal of Neurology, 2025
  • A De Novo SCN2A Variant in a Patient with Adult-Onset Dystonia Parkinsonism and Nigrostriatal Denervation
    Marco Bisquoli, Francesco Cavallieri, Giulia Di Rauso, Edoardo Monfrini, Valentina Fioravanti, Gaetano Salomone, Marco Russo, Romana Rizzi, Alessio Di Fonzo, Franco Valzania
    Movement Disorders Clinical Practice, 2025
  • Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID‐19 task force of the European Academy of Neurology
    Dániel Bereczki, Ádám Dénes, Filippo M. Boneschi, Tamar Akhvlediani, Francesco Cavallieri, Alessandra Fanciulli, Saša R. Filipović, Alla Guekht, Raimund Helbok, Sonja Hochmeister, Tim J. von Oertzen, Serefnur Özturk, Alberto Priori, Martin Rakusa, Barbara Willekens, Elena Moro, Johann Sellner, and
    Journal of Neurology, 2025
  • 18F-FDG PET findings in Parkinson's disease associated to RAB32 S71R variant
    Francesco Cavallieri, Alessandro Fraternali, Annachiara Arnone, Valentina Fioravanti, Edoardo Monfrini, Francesca Di Biasio, Giulia Toschi, Giulia Di Rauso, Giacomo Portaro, Sara Grisanti, Gaetano Salomone, Teresa Kleinz, Paola Mandich, Jefri J. Paul, Christian Beetz, Peter Bauer, Ji Hyun Ko, Matteo Bauckneht, Andrea Melpignano, Angelina Filice, Alessio Di Fonzo, Christine Klein, Antonio P. Strafella, Franco Valzania
    Parkinsonism and Related Disorders, 2025
  • Skin calcium deposits in primary familial brain calcification: A novel potential biomarker
    Aron Emmi, Giulia Bonato, Aleksandar Tushevski, Cinzia Bertolin, Francesco Cavallieri, Andrea Porzionato, Angelo Antonini, Leonardo Salviati, Miryam Carecchio
    Annals of Clinical and Translational Neurology, 2025
  • Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology
    Sonja Hochmeister, Martin Rakusa, Elena Moro, Daniel Bereczki, Francesco Cavallieri, Alessandra Fanciulli, Saša R. Filipović, Alla Guekht, Raimund Helbok, Filippo Martinelli Boneschi, Serefnur Özturk, Alberto Priori, Barbara Willekens, Dauren Ramankulov, Johann Sellner
    Neurological Sciences, 2025
  • Just smile or not? A case of isolated smiling tremor
    Francesco Cavallieri, Giulia Di Rauso, Valentina Fioravanti, Caterina Senesi, Marcello Esposito, Franco Valzania
    Neurological Sciences, 2025
  • Are you tuned in to others' mind? A cross-modal evaluation of affective theory of mind in people with Parkinson's disease
    Elisa Menozzi, Daniela Ballotta, Francesco Cavallieri, Stefania Tocchini, Sara Contardi, Valentina Fioravanti, Franco Valzania, Paolo F. Nichelli, Francesca Benuzzi
    Acta Psychologica, 2025
  • Speech profile in different clinical PSP phenotypes: an acoustic-perceptual study
    Giulia Di Rauso, Francesco Cavallieri, Annalisa Gessani, Davide Fontanesi, Serena Coniglio, Valentina Fioravanti, Sara Contardi, Elisa Menozzi, Francesca Antonelli, Vittorio Rispoli, Franco Valzania, Carla Budriesi
    Neurological Sciences, 2025
  • Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?
    Ilaria Martinelli, Jessica Mandrioli, Andrea Ghezzi, Elisabetta Zucchi, Giulia Gianferrari, Cecilia Simonini, Francesco Cavallieri, Franco Valzania
    Neural Regeneration Research, 2025
  • A Case of Late-Onset Leber’s Hereditary Optic Neuropathy in Association with Heteroplasmic m.11778G>A/ND4 Mutation
    Giacomo Portaro, Francesco Cavallieri, Giulia Amore, Michele Carbonelli, Simone Pelloni, Giuseppe Cavallieri, Valerio Carelli, Franco Valzania, Chiara La Morgia
    Neuro Ophthalmology, 2025
  • Genetic evidence for a link between frontotemporal dementia and Parkinson’s disease: the case of RAB32 Ser71Arg
    Andrea Panzavolta, Francesco Cavallieri, Franco Valzania, Mandy Radefeldt, Sabrina Lemke, Jefri Jeya Paul, Filipa Curado, Peter Bauer, Christian Beetz, Chiara Cerami
    Journal of Neurology, 2025
  • Instrumental balance assessment in Parkinson's disease and parkinsonism. A systematic review with critical appraisal of clinical applications and quality of reporting
    Andrea Merlo, Lorenzo Cavazzuti, Maria Chiara Bò, Francesco Cavallieri, Maria Chiara Bassi, Benedetta Damiano, Sara Scaltriti, Valentina Fioravanti, Giulia Di Rauso, Giacomo Portaro, Franco Valzania, Mirco Lusuardi, Isabella Campanini
    Frontiers in Neurology, 2025
  • Obsessive-compulsive disorder as a first manifestation of Ataxia with Oculomotor Apraxia type 2 due to a novel mutation of SETX gene
    Federica Galota, Giulia Di Rauso, Francesca Sireci, Andrea Castellucci, Francesco Cavallieri, Edoardo Monfrini, Valentina Fioravanti, Isabella Campanini, Andrea Merlo, Manuela Napoli, Lorenzo Cavazzuti, Sara Grisanti, Silvia Ferrari, Alessio Di Fonzo, Franco Valzania
    Neurological Sciences, 2025
  • Genetic and Epidemiological Insights into RAB32-Linked Parkinson's Disease
    Mandy Radefeldt, Sabrina Lemke, Kridsadakorn Chaichoompu, Jefri Jeya Paul, Filipa Curado, Franco Valzania, Francesco Cavallieri, Valentina Fioravanti, Enza Maria Valente, Micol Avenali, Anna Negrotti, Hasmet A. Hanagasi, Sven Thonke, Michele Matarazzo, Andrea Panzavolta, Chiara Cerami, Ana Westenberger, Christine Klein, Peter Bauer, Christian Beetz
    Movement Disorders, 2025
  • The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future
    Francesco Cavallieri, Johann Sellner, Tamar Akhvlediani, Claudio L. Bassetti, Daniel Bereczki, Alessandra Fanciulli, Saša R. Filipović, Alla Guekht, Raimund Helbok, Sonja Hochmeister, Filippo Martinelli Boneschi, Tim J. von Oertzen, Serefnur Özturk, Alberto Priori, Dauren Ramankulov, Barbara Willekens, Martin Rakusa, Elena Moro, the NeuroCOVID‐19 Task Force of the European Academy of Neurology
    European Journal of Neurology, 2025
  • To be or not to be: The dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma – a systematic review and meta-analysis
    Jessica Rossi, Francesco Cavallieri, Maria Chiara Bassi, Francesco Venturelli, Giulia Toschi, Giulia Di Rauso, Chiara Lucchi, Benedetta Donati, Romana Rizzi, Marco Russo, Massimo Bondavalli, Corrado Iaccarino, Giacomo Pavesi, Antonino Neri, Giuseppe Biagini, Alessia Ciarrocchi, Paolo Giorgi Rossi, Anna Pisanello, Franco Valzania
    BMC Cancer, 2024
  • Cerebral Amyloid-β Deposition, Axial Features, and Cognitive Alterations in Patients with Parkinson’s Disease Treated with Bilateral STN-DBS: A Long-Term Cohort Study
    Francesco Cavallieri, Alessandro Fraternali, Annachiara Arnone, Isabella Campanini, Alessandro Marti, Annalisa Gessani, Valentina Fioravanti, Maria Angela Molinari, Giulia Di Rauso, Francesca Antonelli, Vittorio Rispoli, Alberto Feletti, Riccardo Stanzani, Benedetta Damiano, Sara Scaltriti, Lorenzo Cavazzuti, Elisa Bardi, Maria Giulia Corni, Francesca Cavalleri, Giuseppe Biagini, Giacomo Pavesi, Mirco Lusuardi, Carla Budriesi, Andrea Merlo, Annibale Versari, Franco Valzania
    Journal of Personalized Medicine, 2024
  • Family History in Parkinson's Disease: A National Cross-Sectional Study
    Federica Arienti, Giovanni Casazza, Giulia Franco, Giulia Lazzeri, Edoardo Monfrini, Alessandro Di Maio, Roberto Erro, Paolo Barone, Filippo Tamma, Elena Caputo, Maria Antonietta Volontè, Laura Cacciaguerra, Andrea Pilotto, Alessandro Padovani, Cristoforo Comi, Luca Magistrelli, Franco Valzania, Francesco Cavallieri, Laura Avanzino, Roberta Marchese, Mariachiara Sensi, Giorgia Carroli, Roberto Eleopra, Roberto Cilia, Francesca Spagnolo, Alessandro Tessitore, Rosa De Micco, Roberto Ceravolo, Giovanni Palermo, Maria Chiara Malaguti, Leonardo Lopiano, Pierluigi Tocco, Chiara Sorbera, Michele Tinazzi, Andrea Ciammola, Donatella Ottaviani, Enza Maria Valente, Alberto Albanese, Fabio Blandini, Margherita Canesi, Angelo Antonini, Miryam Carecchio, Vincenza Fetoni, Carlo Colosimo, Daniele Volpe, Nicola Tambasco, Giovanni Cossu, Mario Zappia,, Alessio Di Fonzo
    Movement Disorders Clinical Practice, 2024
  • Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement
    Saša R. Filipović, Serefnur Özturk, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Alessandra Fanciulli, Alla Guekht, Raimund Helbok, Sonja Hochmeister, Filippo Martinelli Boneschi, Alberto Priori, Martin Rakusa, Michele Romoli, Barbara Willekens, Marialuisa Zedde, Johann Sellner, Elena Moro, the Neuro COVID‐19 Task Force of the European Academy of Neurology
    European Journal of Neurology, 2024
  • RAB32 mutation in Parkinson's disease [2]
    Edoardo Monfrini, Raffaella Minardi, Franco Valzania, Giovanna Calandra-Buonaura, Paola Mandich, Alessio Di Fonzo, Valerio Carelli, Andrea Gaudio, Agata Fant, Ilaria Palmieri, Valentina Fioravanti, Francesco Cavallieri, Francesca Di Biasio, Alessia Fiorentino, Manuela Vecchi, Paola Origone, Sara Trova, Giovanni Rizzo, Giulia Giannini, Stefano Gambardella, Micol Avenali, Stefano Gustincich, Pietro Cortelli, Fabio Blandini, Enza Maria Valente
    Lancet Neurology, 2024
  • “Somewhere Between an Actual Disease and a Disease”: A Grounded Theory Study on Diagnosing Functional Neurological Disorders From a Multi-Informant Perspective
    Francesca Sireci, Valentina Moretti, Francesco Cavallieri, Silvia Ferrari, Valentina Minardi, Francesca Ferrari, Giulietta Luul Balestra, Luca Ghirotto, Franco Valzania
    Qualitative Health Research, 2024
  • Disentangling Bradykinesia and Rigidity in Parkinson's Disease: Evidence from Short- and Long-Term Subthalamic Nucleus Deep Brain Stimulation
    Alessandro Zampogna, Antonio Suppa, Francesco Bove, Francesco Cavallieri, Anna Castrioto, Sara Meoni, Pierre Pelissier, Emmanuelle Schmitt, Stephan Chabardes, Valerie Fraix, Elena Moro
    Annals of Neurology, 2024
  • Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype?
    Francesco Cavallieri, Chiara Lucchi, Sara Grisanti, Edoardo Monfrini, Valentina Fioravanti, Giulia Toschi, Giulia Di Rauso, Jessica Rossi, Alessio Di Fonzo, Giuseppe Biagini, Franco Valzania
    Biomolecules, 2024
  • Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study
    Ana Westenberger, Volha Skrahina, Tatiana Usnich, Christian Beetz, Eva-Juliane Vollstedt, Björn-Hergen Laabs, Jefri J Paul, Filipa Curado, Snezana Skobalj, Hanaa Gaber, Maria Olmedillas, Xenia Bogdanovic, Najim Ameziane, Nathalie Schell, Jan Olav Aasly, Mitra Afshari, Pinky Agarwal, Jason Aldred, Fernando Alonso-Frech, Roderick Anderson, Rui Araújo, David Arkadir, Micol Avenali, Mehmet Balal, Sandra Benizri, Sagari Bette, Perminder Bhatia, Michael Bonello, Pedro Braga-Neto, Sarah Brauneis, Francisco Eduardo Costa Cardoso, Francesco Cavallieri, Joseph Classen, Lisa Cohen, Della Coletta, David Crosiers, Paskal Cullufi, Khashayar Dashtipour, Meltem Demirkiran, Patricia de Carvalho Aguiar, Anna De Rosa, Ruth Djaldetti, Okan Dogu, Maria Gabriela dos Santos Ghilardi, Carsten Eggers, Bulent Elibol, Aaron Ellenbogen, Sibel Ertan, Giorgio Fabiani, Björn H Falkenburger, Simon Farrow, Tsviya Fay-Karmon, Gerald J Ferencz, Erich Talamoni Fonoff, Yara Dadalti Fragoso, Gençer Genç, Arantza Gorospe, Francisco Grandas, Doreen Gruber, Mark Gudesblatt, Tanya Gurevich, Johann Hagenah, Hasmet A Hanagasi, Sharon Hassin-Baer, Robert A Hauser, Jorge Hernández-Vara, Birgit Herting, Vanessa K Hinson, Elliot Hogg, Michele T Hu, Eduardo Hummelgen, Kelly Hussey, Jon Infante, Stuart H Isaacson, Serge Jauma, Natalia Koleva-Alazeh, Gregor Kuhlenbäumer, Andrea Kühn, Irene Litvan, Lydia López-Manzanares, McKenzie Luxmore, Sujeena Manandhar, Veronique Marcaud, Katerina Markopoulou, Connie Marras, Mark McKenzie, Michele Matarazzo, Marcelo Merello, Brit Mollenhauer, John C Morgan, Stephen Mullin, Thomas Musacchio, Bennett Myers, Anna Negrotti, Anette Nieves, Zeev Nitsan, Nader Oskooilar, Özgür Öztop-Çakmak, Gian Pal, Nicola Pavese, Antonio Percesepe, Tommaso Piccoli, Carolina Pinto de Souza, Tino Prell, Mark Pulera, Jason Raw, Kathrin Reetz, Johnathan Reiner, David Rosenberg, Marta Ruiz-Lopez, Javier Ruiz Martinez, Esther Sammler, Bruno Lopes Santos-Lobato, Rachel Saunders-Pullman, Ilana Schlesinger, Christine M Schofield, Artur F Schumacher-Schuh, Burton Scott, Ángel Sesar, Stuart J Shafer, Ray Sheridan, Monty Silverdale, Rani Sophia, Mariana Spitz, Pantelis Stathis, Fabrizio Stocchi, Michele Tagliati, Yen F Tai, Annelies Terwecoren, Sven Thonke, Lars Tönges, Giulia Toschi, Vitor Tumas, Peter Paul Urban, Laura Vacca, Wim Vandenberghe, Enza Maria Valente, Franco Valzania, Lydia Vela-Desojo, Caroline Weill, David Weise, Joanne Wojcieszek, Martin Wolz, Gilad Yahalom, Gul Yalcin-Cakmakli, Simone Zittel, Yair Zlotnik, Krishna K Kandaswamy, Alexander Balck, Henrike Hanssen, Max Borsche, Lara M Lange, Ilona Csoti, Katja Lohmann, Meike Kasten, Norbert Brüggemann, Arndt Rolfs, Christine Klein, Peter Bauer
    Brain, 2024
  • Exploring therapeutic interventions for functional neurological disorders: a comprehensive scoping review
    Francesca Sireci, Federica Ragucci, Chiara Menozzi, Maria Paola Cabboi, Livio Picchetto, Maria Chiara Bassi, Luca Ghirotto, Francesco Cavallieri, Cristina Pedroni, Franco Valzania
    Journal of Neurology, 2024
  • Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease
    Massimo Marano, Carmela Zizzo, Maria Chiara Malaguti, Ruggero Bacchin, Francesco Cavallieri, Rosa De Micco, Francesca Spagnolo, Anna Rita Bentivoglio, Tommaso Schirinzi, Roberta Bovenzi, Silvia Ramat, Roberto Erro, Cristiano Sorrentino, Patrizia Sucapane, Andrea Pilotto, Alessandro Lupini, Alessandro Magliozzi, Ilaria Di Vico, Miryam Carecchio, Giulia Bonato, Roberto Cilia, Fabiana Colucci, Filippo Tamma, Elena Caputo, Giovanni Mostile, Gennarina Arabia, Nicola Modugno, Maurizio Zibetti, Maria Gabriella Ceravolo, Nicola Tambasco, Giovanni Cossu, Franco Valzania, Paolo Manganotti, Vincenzo Di Lazzaro, Mario Zappia, Giovanni Fabbrini, Michele Tinazzi, Alessandro Tessitore, Giovanni Duro, Alessio Di Fonzo
    Parkinsonism and Related Disorders, 2024
  • Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry
    Maurizio Angelo Leone, Raimund Helbok, Elisa Bianchi, Clarissa Lin Yasuda, Maria Konti, Dauren Ramankulov, Maria Lolich, Arijana Lovrencic-Huzjan, Tibor Kovács, Carmel Armon, Maria Sofia Cotelli, Francesco Cavallieri, Oxana Grosu, Gordana Kiteva-Trenchevska, Ildefonso Rodriguez-Leyva, Marion Boldingh, Waldemar Brola, Luís F. Maia, Mafalda Maria Laracho de Seabra, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu, Svetlana Kopishinskaia, Claudio L. A. Bassetti, Elena Moro, the ENERGY Study Group (§), Khachik Petrosyan, Philipp Kindl, Ingomar Krehan, Johan Sellner, Edith Kohler, Lucas Scardua, Simon Jung, Jitka Bušková, Lars Wojtecki, Pille Taba, Sara Meoni, Thomas Michael Jenkins, Ivana Vinski, Dániel Bereczki, Netta Agajany, Marta Bianchi, Marinella Turla, Franco Valzania, Giulia Toschi, Jessica Rossi, Odainic Olesea, Plesca Svetlana, Manole Elena, Rafael Avalos-Pavon, Anne Hege Aamodt, Vojtech Novotny, Annette Huuse Farmen, Heidi Øyen Flemmen, Katarzyna Siutka, Elaine Santos, Bárbara Pinto Martins, Irina Odajiu, Constantin Dragos Sandu, Anca Covaliu, Ana Jugurt, Maria Zakharova, Vasilya Idiiatova, Serefnur Ozturk
    Journal of Neurology, 2024
  • The history of deep brain stimulation
    Francesco Cavallieri, Eoin Mulroy, Elena Moro
    Parkinsonism and Related Disorders, 2024
  • A Case of 18p Chromosomal Deletion Encompassing GNAL in a Patient With Dystonia-Parkinsonism
    Giulia Di Rauso, Francesco Cavallieri, Edoardo Monfrini, Alessandro Fraternali, Valentina Fioravanti, Sara Grisanti, Annalisa Gessani, Isabella Campanini, Andrea Merlo, Giulia Toschi, Manuela Napoli, Rosario Pascarella, Rosamaria Silipigni, Palma Finelli, Jefri J. Paul, Peter Bauer, Annibale Versari, Alessio Di Fonzo, Franco Valzania
    Journal of Movement Disorders, 2024
  • Caregivers' burden and deep brain stimulation for Parkinson disease: A systematic review of qualitative studies
    Francesco Cavallieri, Luca Ghirotto, Francesca Sireci, Margherita Parmeggiani, Cristina Pedroni, Felipe Andres Mardones, Maria Chiara Bassi, Valentina Fioravanti, Valérie Fraix, Elena Moro, Franco Valzania
    European Journal of Neurology, 2024
  • The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics
    Martin Rakusa, Elena Moro, Tamar Akhvlediani, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Alessandra Fanciulli, Saša R. Filipović, Alla Guekht, Raimund Helbok, Sonja Hochmeister, Filippo Martinelli Boneschi, Serefnur Özturk, Alberto Priori, Michele Romoli, Barbara Willekens, Marialuisa Zedde, Johann Sellner, the NeuroCOVID‐19 Task Force of the European Academy of Neurology
    European Journal of Neurology, 2024
  • Olfactory status in neurodegeneration with brain iron accumulation disorders
    Elahe Amini, Mohammad Rohani, Maryam Jalessi, Zahra Azad, Franco Valzania, Francesco Cavallieri, Mohammad Farhadi, Zeinab Gholibeigian
    Neurological Sciences, 2024
  • Longitudinal Neuropsychological Assessment of Symptomatic Edema after Subthalamic Nucleus Deep Brain Stimulation Surgery: A Case Series Study
    Silvia De Ieso, Giulia Di Rauso, Francesco Cavallieri, Daniela Beltrami, Alessandro Marti, Manuela Napoli, Rosario Pascarella, Alberto Feletti, Valentina Fioravanti, Giulia Toschi, Vittorio Rispoli, Francesca Antonelli, Annette Puzzolante, Giacomo Pavesi, Federico Gasparini, Franco Valzania
    Neurology International, 2024
  • Pathophysiology of COVID‐19‐Related Extrapyramidal Disorders
    Francesco Cavallieri, Marialuisa Zedde, Valentina Fioravanti, Sara Grisanti, Manuela Napoli, Claudio Moratti, Rosario Pascarella, Elena Moro, Franco Valzania
    Advances in Experimental Medicine and Biology, 2024
  • Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities
    Rodolfo Molina-Peña, Natália Helen Ferreira, Charlotte Roy, Loris Roncali, Mathie Najberg, Sylvie Avril, Mariana Zarur, William Bourgeois, Alba Ferreirós, Chiara Lucchi, Francesco Cavallieri, François Hindré, Giovani Tosi, Giuseppe Biagini, Franco Valzania, François Berger, Miguel Abal, Audrey Rousseau, Frank Boury, Carmen Alvarez-Lorenzo, Emmanuel Garcion
    Acta Biomaterialia, 2024
  • Vestibular Hypofunction in ARSACS Syndrome A Possible Pitfall in the Differential Diagnosis of Recessive Cerebellar and Afferent Ataxias
    Giacomo Argenziano, Francesco Cavallieri, Andrea Castellucci, Valentina Fioravanti, Giulia Di Rauso, Annalisa Gessani, Isabella Campanini, Andrea Merlo, Manuela Napoli, Sara Grisanti, Jessica Rossi, Giulia Toschi, Chiara Zini, Angelo Ghidini, Franco Valzania
    Neurology Clinical Practice, 2023
  • Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson’s disease
    Annalisa Gessani, Francesco Cavallieri, Valentina Fioravanti, Isabella Campanini, Andrea Merlo, Giulia Di Rauso, Benedetta Damiano, Sara Scaltriti, Elisa Bardi, Maria Giulia Corni, Francesca Antonelli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Alessandro Fraternali, Annibale Versari, Giuseppe Biagini, Valérie Fraix, Serge Pinto, Elena Moro, Carla Budriesi, Franco Valzania
    Scientific Reports, 2023
  • Author Correction: Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson’s disease (Scientific Reports, (2023), 13, 1, (11462), 10.1038/s41598-023-38555-2)
    Annalisa Gessani, Francesco Cavallieri, Valentina Fioravanti, Isabella Campanini, Andrea Merlo, Giulia Di Rauso, Benedetta Damiano, Sara Scaltriti, Elisa Bardi, Maria Giulia Corni, Francesca Antonelli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Alessandro Fraternali, Annibale Versari, Giuseppe Biagini, Valérie Fraix, Serge Pinto, Elena Moro, Carla Budriesi, Franco Valzania
    Scientific Reports, 2023
  • Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort
    Micol Avenali, Roberta Zangaglia, Giada Cuconato, Ilaria Palmieri, Alberto Albanese, Carlo Alberto Artusi, Marco Bozzali, Giovanna Calandra-Buonaura, Francesco Cavallieri, Roberto Cilia, Antoniangela Cocco, Filippo Cogiamanian, Fabiana Colucci, Pietro Cortelli, Alessio Di Fonzo, Roberto Eleopra, Giulia Giannini, Alberto Imarisio, Gabriele Imbalzano, Claudia Ledda, Leonardo Lopiano, Maria Chiara Malaguti, Francesca Mameli, Raffaella Minardi, Pierfrancesco Mitrotti, Edoardo Monfrini, Francesca Spagnolo, Cristina Tassorelli, Francesca Valentino, Franco Valzania, Claudio Pacchetti, Enza Maria Valente
    Journal of Neurology Neurosurgery and Psychiatry, 2023
  • Speech, Gait, and Vestibular Function in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome
    Giulia Di Rauso, Andrea Castellucci, Francesco Cavallieri, Andrea Tozzi, Valentina Fioravanti, Edoardo Monfrini, Annalisa Gessani, Jessica Rossi, Isabella Campanini, Andrea Merlo, Dario Ronchi, Manuela Napoli, Rosario Pascarella, Sara Grisanti, Giuseppe Ferrulli, Rossella Sabadini, Alessio Di Fonzo, Angelo Ghidini, Franco Valzania
    Brain Sciences, 2023
  • Axial Improvement after Casirivimab/Imdevimab Treatment for COVID-19 in Parkinson's Disease
    Valentina Fioravanti, Francesco Cavallieri, Alessio Di Fonzo, Giulia Toschi, Sara Grisanti, Gaetano Salomone, Mario Zappia, Franco Valzania
    Canadian Journal of Neurological Sciences, 2023
  • Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson’s disease: a clinical-instrumental study
    Francesco Cavallieri, Isabella Campanini, Annalisa Gessani, Carla Budriesi, Valentina Fioravanti, Giulia Di Rauso, Alberto Feletti, Benedetta Damiano, Sara Scaltriti, Noemi Guagnano, Elisa Bardi, Maria Giulia Corni, Jessica Rossi, Francesca Antonelli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Annette Puzzolante, Giuseppe Vannozzi, Elena Bergamini, Giacomo Pavesi, Sara Meoni, Valérie Fraix, Alessandro Fraternali, Annibale Versari, Mirco Lusuardi, Giuseppe Biagini, Andrea Merlo, Elena Moro, Franco Valzania
    Journal of Neurology, 2023
  • Levodopa responsive asymmetric parkinsonism as clinical presentation of progranulin gene mutation.
    Niccolò Biagioli, Francesco Cavallieri, Alessandro Marti, Giulia Di Rauso, Valentina Fioravanti, Edoardo Monfrini, Federico Gasparini, Daniela Beltrami, Sara Grisanti, Jessica Rossi, Giulia Toschi, Alessandro Fraternali, Annibale Versari, Manuela Napoli, Rosario Pascarella, Alessio Di Fonzo, Franco Valzania
    Journal of the Neurological Sciences, 2023
  • Quantitative dopamine transporter imaging assessment in Parkinson's disease patients carrying GBA gene mutations compared with idiopathic PD patients: A case-control study
    Sara Grisanti, Alessandro Fraternali, Francesco Cavallieri, Valentina Fioravanti, Massimiliano Casali, Giulia Toschi, Laura Ferri, Rossella Sabadini, Marialuisa Zedde, Gaetano Salomone, Manuela Napoli, Rosario Pascarella, Valeria Ferrari, Maria Scarano, Giuseppe Biagini, Augusto Scaglioni, Elena Moro, Annibale Versari, Franco Valzania
    Brain and Behavior, 2023
  • Insights into Healthcare Professionals’ Perceptions and Attitudes toward Nanotechnological Device Application: What Is the Current Situation in Glioblastoma Research?
    Federica Ragucci, Francesca Sireci, Francesco Cavallieri, Jessica Rossi, Giuseppe Biagini, Giovanni Tosi, Chiara Lucchi, Rodolfo Molina-Pena, Natalia Helen Ferreira, Mariana Zarur, Alba Ferreiros, William Bourgeois, François Berger, Miguel Abal, Audrey Rousseau, Frank Boury, Carmen Alvarez-Lorenzo, Emmanuel Garcion, Anna Pisanello, Giacomo Pavesi, Corrado Iaccarino, Luca Ghirotto, Maria Chiara Bassi, Franco Valzania
    Biomedicines, 2023
  • Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment
    Francesco Cavallieri, Annalisa Gessani, Andrea Merlo, Isabella Campanini, Carla Budriesi, Valentina Fioravanti, Giulia Di Rauso, Alberto Feletti, Benedetta Damiano, Sara Scaltriti, Noemi Guagnano, Elisa Bardi, Maria Giulia Corni, Francesca Antonelli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Annette Puzzolante, Giuseppe Vannozzi, Elena Bergamini, Giacomo Pavesi, Valérie Fraix, Sara Meoni, Alessandro Fraternali, Annibale Versari, Mirco Lusuardi, Giuseppe Biagini, Serge Pinto, Elena Moro, Franco Valzania
    European Journal of Neurology, 2023
  • Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
    Francesco Cavallieri, Rubens G. Cury, Thiago Guimarães, Valentina Fioravanti, Sara Grisanti, Jessica Rossi, Edoardo Monfrini, Marialuisa Zedde, Alessio Di Fonzo, Franco Valzania, Elena Moro
    Cells, 2023
  • Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review
    Jessica Rossi, Francesco Cavallieri, Maria Chiara Bassi, Giuseppe Biagini, Romana Rizzi, Marco Russo, Massimo Bondavalli, Corrado Iaccarino, Giacomo Pavesi, Salvatore Cozzi, Lucia Giaccherini, Masoumeh Najafi, Anna Pisanello, Franco Valzania
    Biomedicines, 2023
  • Deconstructing speech alterations in episodic ataxia type 2: Perceptual-acoustic analysis in a case due to CACNA1A gene mutation
    Giacomo Argenziano, Francesco Cavallieri, Edoardo Monfrini, Annalisa Gessani, Marco Russo, Romana Rizzi, Valentina Fioravanti, Sara Grisanti, Giulia Toschi, Manuela Napoli, Rosario Pascarella, Carla Budriesi, Alessio Di Fonzo, Riccardo Zucco, Franco Valzania
    Parkinsonism and Related Disorders, 2023
  • Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review
    Masoumeh Najafi, Amin Jahanbakhshi, Sebastiano Finocchi Ghersi, Lucia Giaccherini, Andrea Botti, Francesco Cavallieri, Jessica Rossi, Federico Iori, Cinzia Iotti, Patrizia Ciammella, Mohsen Nabiuni, Marzieh Gomar, Omid Rezaie, Salvatore Cozzi
    Brain Sciences, 2023
  • Comparative features and outcomes of major neurological complications of COVID-19
    Ettore Beghi, Elena Moro, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu, Oxana Grosu, Franco Valzania, Maria Sofia Cotelli, Gordana Kiteva‐Trenchevska, Maria Zakharova, Tibor Kovács, Carmel Armon, Waldemar Brola, Clarissa Lin Yasuda, Luís F. Maia, Arijana Lovrencic‐Huzjan, Mafalda Maria Laracho de Seabra, Rafael Avalos‐Pavon, Anne Hege Aamodt, Sara Meoni, Victoria Gryb, Serefnur Ozturk, Omer Karadas, Ingomar Krehan, Maurizio A. Leone, Maria Lolich, Elisa Bianchi, Verena Rass, Raimund Helbok, Claudio L. A. Bassetti, the ENERGY Study Group
    European Journal of Neurology, 2023
  • Case Report: Pituitary metastasis as a presenting manifestation of silent gastric cardia adenocarcinoma
    Andrea Ghezzi, Jessica Rossi, Francesco Cavallieri, Manuela Napoli, Rosario Pascarella, Romana Rizzi, Marco Russo, Gaetano Salomone, Antonio Romano, Corrado Iaccarino, Elisabetta Froio, Silvia Serra, Salvatore Cozzi, Lucia Giaccherini, Franco Valzania, Anna Pisanello
    Frontiers in Oncology, 2023
  • A study on the correlations between acoustic speech variables and bradykinesia in advanced Parkinson's disease
    Francesco Cavallieri, Giulia Di Rauso, Annalisa Gessani, Carla Budriesi, Valentina Fioravanti, Sara Contardi, Elisa Menozzi, Serge Pinto, Elena Moro, Francesca Antonelli, Franco Valzania
    Frontiers in Neurology, 2023
  • Epilepsy in patients undergoing cardiac surgery with ExtraCorporeal Circulation: case series and description of a peculiar clinical phenotype
    Matteo Pugnaghi, Francesco Cavallieri, Mauro Zennaro, Marialuisa Zedde, Romana Rizzi, Davide Gabbieri, Franco Valzania
    BMC Neurology, 2022
  • Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
    Marialuisa Zedde, Rosario Pascarella, Francesco Cavallieri, Francesca Romana Pezzella, Sara Grisanti, Alessio Di Fonzo, Franco Valzania
    Biomedicines, 2022
  • Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
    Alessandro Zampogna, Francesco Cavallieri, Francesco Bove, Antonio Suppa, Anna Castrioto, Sara Meoni, Pierre Pélissier, Emmanuelle Schmitt, Amélie Bichon, Eugénie Lhommée, Andrea Kistner, Stephan Chabardès, Eric Seigneuret, Valerie Fraix, Elena Moro
    Npj Parkinson S Disease, 2022
  • Ataxia-Myoclonus Syndrome in Patients with SARS-CoV-2 Infection
    Anna Francesca Guerra, Ilaria Martinelli, Vittorio Rispoli, Matteo Marcacci, Francesco Cavallieri, Silvia Nizzoli, Franco Valzania, Paolo Ventura, Stefano Meletti, Antonello Pietrangelo
    Canadian Journal of Neurological Sciences, 2022
  • Subcortical generalized myoclonus as a presenting symptom of quetiapine overdose
    Valentina Fioravanti, Francesco Cavallieri, Jessica Rossi, Maria Catena Macaluso, Franco Valzania
    Neurological Sciences, 2022
  • Mechanisms and Neuroimaging Patterns of Hypereosinophilia-Related Ischemic Stroke: A Narrative Review through Three Cases
    Maria Cristina Cioclu, Francesco Cavallieri, Manuela Napoli, Claudio Moratti, Rosario Pascarella, Franco Valzania, Marialuisa Zedde
    Journal of Clinical Medicine, 2022
  • Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case
    Marialuisa Zedde, Giacomo Portaro, Laura Ferri, Francesco Cavallieri, Manuela Napoli, Claudio Moratti, Fabrizio Piazza, Franco Valzania, Rosario Pascarella
    Journal of Clinical Medicine, 2022
  • Epileptogenesis and Tumorigenesis in Glioblastoma: Which Relationship?
    Jessica Rossi, Francesco Cavallieri, Giuseppe Biagini, Romana Rizzi, Marco Russo, Salvatore Cozzi, Lucia Giaccherini, Anna Pisanello, Franco Valzania
    Medicina Lithuania, 2022
  • Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL)
    Patrizia Ciammella, Salvatore Cozzi, Andrea Botti, Lucia Giaccherini, Roberto Sghedoni, Matteo Orlandi, Manuela Napoli, Rosario Pascarella, Anna Pisanello, Marco Russo, Francesco Cavallieri, Maria Paola Ruggieri, Silvio Cavuto, Luisa Savoldi, Cinzia Iotti, Mauro Iori
    Cancers, 2022
  • Freezing of Gait in Parkinson’s Disease Patients Treated with Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Long-Term Overview
    Giulia Di Rauso, Francesco Cavallieri, Isabella Campanini, Annalisa Gessani, Valentina Fioravanti, Alberto Feletti, Benedetta Damiano, Sara Scaltriti, Elisa Bardi, Maria Giulia Corni, Francesca Antonelli, Vittorio Rispoli, Francesca Cavalleri, Maria Angela Molinari, Sara Contardi, Elisa Menozzi, Annette Puzzolante, Jessica Rossi, Stefano Meletti, Giuseppe Biagini, Giacomo Pavesi, Valerie Fraix, Mirco Lusuardi, Alessandro Fraternali, Annibale Versari, Carla Budriesi, Elena Moro, Andrea Merlo, Franco Valzania
    Biomedicines, 2022
  • COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper
    Martin Rakusa, Serefnur Öztürk, Elena Moro, Raimund Helbok, Claudio L. Bassetti, Ettore Beghi, Daniel Bereczki, Benedetta Bodini, Giovanni Di Liberto, Thomas M. Jenkins, Antonella Macerollo, Luis F. Maia, Filippo Martinelli‐Boneschi, Antonio Pisani, Alberto Priori, Anna Sauerbier, Riccardo Soffietti, Pille Taba, Tim J. von Oertzen, Marialuisa Zedde, Michael Crean, Anja Burlica, Francesco Cavallieri, Johann Sellner, the European Academy of Neurology NeuroCOVID‐19 Task Force
    European Journal of Neurology, 2022
  • COVID-19 and Parkinsonism: A Critical Appraisal
    Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, Marialuisa Zedde, Rosario Pascarella, Elena Moro, Franco Valzania
    Biomolecules, 2022
  • Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?
    Francesco Bove, Francesco Cavallieri, Anna Castrioto, Sara Meoni, Emmanuelle Schmitt, Amélie Bichon, Eugénie Lhommée, Pierre Pélissier, Andrea Kistner, Eric Chevrier, Eric Seigneuret, Stephan Chabardès, Franco Valzania, Valerie Fraix, Elena Moro
    Frontiers in Human Neuroscience, 2022
  • Needs and Perceptions of Patients With Dystonia During the COVID-19 Pandemic: A Qualitative Framework Analysis of Survey Responses From Italy
    Vittorio Rispoli, Matías Eduardo Díaz Crescitelli, Francesco Cavallieri, Francesca Antonelli, Stefano Meletti, Luca Ghirotto, Franco Valzania
    Frontiers in Neurology, 2022
  • Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19
    Ettore Beghi, Raimund Helbok, Serefnur Ozturk, Omer Karadas, Vitalie Lisnic, Oxana Grosu, Tibor Kovács, Levente Dobronyi, Daniel Bereczki, Maria Sofia Cotelli, Marinella Turla, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu, Franco Valzania, Francesco Cavallieri, Hanno Ulmer, Luis F. Maia, Anne Hege Amodt, Carmel Armon, Waldemer Brola, Gryb Victoria, Anis Riahi, Ingomar Krehan, Tim von Oertzen, Mohammed A Azab, Michael Crean, Maria Lolich, Maria João Lima, Johann Sellner, Julian Perneczky, Tom Jenkins, Sara Meoni, Elisa Bianchi, Elena Moro, Claudio L. A. Bassetti, the ENERGY Study Group
    European Journal of Neurology, 2022
  • Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
    Bhagteshwar Singh, Suzannah Lant, Sofia Cividini, Jonathan W. S. Cattrall, Lynsey C. Goodwin, Laura Benjamin, Benedict D. Michael, Ayaz Khawaja, Aline de Moura Brasil Matos, Walid Alkeridy, Andrea Pilotto, Durjoy Lahiri, Rebecca Rawlinson, Sithembinkosi Mhlanga, Evelyn C. Lopez, Brendan F. Sargent, Anushri Somasundaran, Arina Tamborska, Glynn Webb, Komal Younas, Yaqub Al Sami, Heavenna Babu, Tristan Banks, Francesco Cavallieri, Matthew Cohen, Emma Davies, Shalley Dhar, Anna Fajardo Modol, Hamzah Farooq, Jeffrey Harte, Samuel Hey, Albert Joseph, Dileep Karthikappallil, Daniel Kassahun, Gareth Lipunga, Rachel Mason, Thomas Minton, Gabrielle Mond, Joseph Poxon, Sophie Rabas, Germander Soothill, Marialuisa Zedde, Konstantin Yenkoyan, Bruce Brew, Erika Contini, Lucette Cysique, Xin Zhang, Pietro Maggi, Vincent van Pesch, Jérome Lechien, Sven Saussez, Alex Heyse, Maria Lúcia Brito Ferreira, Cristiane N. Soares, Isabel Elicer, Laura Eugenín-von Bernhardi, Waleng Ñancupil Reyes, Rong Yin, Mohammed A. Azab, Foad Abd-Allah, Ahmed Elkady, Simon Escalard, Jean-Christophe Corvol, Cécile Delorme, Pierre Tattevin, Kévin Bigaut, Norbert Lorenz, Daniel Hornuss, Jonas Hosp, Siegbert Rieg, Dirk Wagner, Benjamin Knier, Paul Lingor, Andrea Sylvia Winkler, Athena Sharifi-Razavi, Shima T. Moein, SeyedAhmad SeyedAlinaghi, Saeidreza JamaliMoghadamSiahkali, Mauro Morassi, Alessandro Padovani, Marcello Giunta, Ilenia Libri, Simone Beretta, Sabrina Ravaglia, Matteo Foschi, Paolo Calabresi, Guido Primiano, Serenella Servidei, Nicola Biagio Mercuri, Claudio Liguori, Mariangela Pierantozzi, Loredana Sarmati, Federica Boso, Silvia Garazzino, Sara Mariotto, Kimani N. Patrick, Oana Costache, Alexander Pincherle, Frederikus A. Klok, Roger Meza, Verónica Cabreira, Sofia R. Valdoleiros, Vanessa Oliveira, Igor Kaimovsky, Alla Guekht, Jasmine Koh, Eva Fernández Díaz, José María Barrios-López, Cristina Guijarro-Castro, Álvaro Beltrán-Corbellini, Javier Martínez-Poles, Alba María Diezma-Martín, Maria Isabel Morales-Casado, Sergio García García, Gautier Breville, Matteo Coen, Marjolaine Uginet, Raphaël Bernard-Valnet, Renaud Du Pasquier, Yildiz Kaya, Loay H. Abdelnour, Claire Rice, Hamish Morrison, Sylviane Defres, Saif Huda, Noelle Enright, Jane Hassell, Lucio D’Anna, Matthew Benger, Laszlo Sztriha, Eamon Raith, Krishna Chinthapalli, Ross Nortley, Ross Paterson, Arvind Chandratheva, David J. Werring, Samir Dervisevic, Kirsty Harkness, Ashwin Pinto, Dinesh Jillella, Scott Beach, Kulothungan Gunasekaran, Ivan Rocha Ferreira Da Silva, Krishna Nalleballe, Jonathan Santoro, Tyler Scullen, Lora Kahn, Carla Y. Kim, Kiran T. Thakur, Rajan Jain, Thirugnanam Umapathi, Timothy R. Nicholson, James J. Sejvar, Eva Maria Hodel, Catrin Tudur Smith, Tom Solomon, and
    Plos One, 2022
  • Co-Occurrence of Multiple Sclerosis and Amyotrophic Lateral Sclerosis in an FUS-Mutated Patient: A Case Report
    Luigi Fiondella, Francesco Cavallieri, Elena Canali, Maria Paola Cabboi, Alessandro Marti, Francesca Sireci, Alena Fiocchi, Gloria Montanari, Sara Montepietra, Franco Valzania
    Brain Sciences, 2022
  • Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype?
    Jessica Rossi, Francesco Cavallieri, Giada Giovannini, Francesca Benuzzi, Daniela Ballotta, Anna Elisabetta Vaudano, Francesca Ferrara, Sara Contardi, Antonello Pietrangelo, Elena Corradini, Fausta Lui, Stefano Meletti
    Brain Sciences, 2022
  • Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations
    Sara Grisanti, Laura Ferri, Francesco Cavallieri, Valentina Fioravanti, Chiara Vincenzi, Giulia Toschi, Ilaria Grisendi, Rossella Sabadini, Jefri J. Paul, Peter Bauer, Marialuisa Zedde, Franco Valzania
    Movement Disorders, 2022
  • State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis
    Masoumeh Najafi, Amin Jahanbakhshi, Marzieh Gomar, Cinzia Iotti, Lucia Giaccherini, Omid Rezaie, Francesco Cavallieri, Letizia Deantonio, Lilia Bardoscia, Andrea Botti, Angela Sardaro, Salvatore Cozzi, Patrizia Ciammella
    Current Oncology, 2022
  • Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study
    F. Mo, S. Meletti, V. Belcastro, S. Quadri, M. Napolitano, L. Bello, F. Dainese, M. Scarpelli, I. Florindo, A. Mascia, G. Pauletto, F. Bruno, A. Pellerino, G. Giovannini, M. Polosa, M. Sessa, M. Conti Nibali, G. Di Gennaro, G. L. Gigli, A. Pisanello, F. Cavallieri, R. Rudà
    Journal of Neuro Oncology, 2022
  • Neurologic complications of coronavirus and other respiratory viral infections
    Francesco Cavallieri, Johann Sellner, Marialuisa Zedde, Elena Moro
    Handbook of Clinical Neurology, 2022
  • Adult onset familiar dystonia-plus syndrome: A novel presentation of IRF2BPL-associated neurodegeneration
    Francesca Antonelli, Gaetano Grieco, Francesco Cavallieri, Antonella Casella, Enza Maria Valente
    Parkinsonism and Related Disorders, 2022
  • Bow hunter’s syndrome successfully treated with a posterior surgical decompression approach: A case report and review of literature
    Niccolò Orlandi, Francesco Cavallieri, Ilaria Grisendi, Antonio Romano, Reza Ghadirpour, Manuela Napoli, Claudio Moratti, Matteo Zanichelli, Rosario Pascarella, Franco Valzania, Marialuisa Zedde
    World Journal of Clinical Cases, 2022
  • COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration?
    Francesco Cavallieri, Valentina Fioravanti, Giulia Toschi, Sara Grisanti, Manuela Napoli, Claudio Moratti, Rosario Pascarella, Annibale Versari, Alessandro Fraternali, Massimiliano Casali, Jefri J. Paul, Elena Moro, Peter Bauer, Marialuisa Zedde, Franco Valzania
    Journal of Neurology, 2022
  • Adult-onset KMT2B-related dystonia
    Edoardo Monfrini, Andrea Ciolfi, Francesco Cavallieri, Marco Ferilli, Paola Soliveri, Lucia Pedace, Roberto Erro, Francesca Del Sorbo, Franco Valzania, Valentina Fioravanti, Giovanni Cossu, Maria Pellegrini, Leonardo Salviati, Federica Invernizzi, Valentina Oppo, Daniela Murgia, Bruno Giometto, Marina Picillo, Barbara Garavaglia, Francesca Morgante, Marco Tartaglia, Miryam Carecchio, Alessio Di Fonzo
    Brain Communications, 2022
  • Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey
    Benedetta Bodini, Elena Moro, Joke Jaarsma, Elizabeth Cunningham, Johann Sellner, Donna Walsh, the EANcore COVID‐19 Task Force
    European Journal of Neurology, 2022
  • Glioblastoma and malignant melanoma: Serendipitous or anticipated association?
    Luigi Fiondella, Francesco Cavallieri, Manuela Napoli, Elisabetta Froio, Silvia Serra, Stefania Borsari, Lucia Giaccherini, Reza Ghadirpour, Salvatore Cozzi, Rosario Pascarella, Caterina Longo, Franco Valzania, Anna Pisanello
    Neuropathology, 2021
  • A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology
    Johann Sellner, Thomas M. Jenkins, Tim J. von Oertzen, Claudio L. Bassetti, Ettore Beghi, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Giovanni Di Liberto, Raimund Helbok, Antonella Macerollo, Luis F. Maia, Celia Oreja‐Guevara, Serefnur Özturk, Martin Rakusa, Antonio Pisani, Alberto Priori, Anna Sauerbier, Riccardo Soffietti, Pille Taba, Marialuisa Zedde, Michael Crean, Anja Burlica, Alex Twardzik, Elena Moro, for the EAN NeuroCOVID‐19 Task Force
    European Journal of Neurology, 2021
  • Opicapone and acute levodopa challenge test: the big issue
    Francesco Cavallieri, Valentina Fioravanti, Franco Valzania
    Acta Neurologica Belgica, 2021
  • Parkinson's disease patients' needs during the COVID-19 pandemic in a red zone: A framework analysis of open-ended survey questions
    Francesco Cavallieri, Francesca Sireci, Valentina Fioravanti, Giulia Toschi, Vittorio Rispoli, Francesca Antonelli, Massimo Costantini, Luca Ghirotto, Franco Valzania
    European Journal of Neurology, 2021
  • The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19
    Ettore Beghi, Raimund Helbok, Michael Crean, Sherry Hsiang‐Yi Chou, Molly McNett, Elena Moro, Claudio Bassetti, for the EAN Neuro‐COVID Task Force
    European Journal of Neurology, 2021
  • Primary prevention of COVID-19: Advocacy for vaccination from a neurological perspective
    Johann Sellner, Thomas M. Jenkins, Tim J. von Oertzen, Claudio L. Bassetti, Ettore Beghi, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Giovanni Di Liberto, Raimund Helbok, Antonella Macerollo, Luis F. Maia, Celia Oreja‐Guevara, Serefnur Özturk, Martin Rakusa, Anna Sauerbier, Riccardo Soffietti, Pille Taba, Antonio Pisani, Alberto Priori, Marialuisa Zedde, Michael Crean, Anja Burlica, Alex Twardzik, Elena Moro, the EAN NeuroCOVID‐19 Task Force
    European Journal of Neurology, 2021
  • Peribuccal and pharyngeal myorhythmia as a presenting symptom of hypertrophic olivary degeneration
    Federica Assenza, Maurilio Genovese, Maria Paola Cabboi, Gaetano Salomone, Francesco Cavallieri, Franco Valzania
    Parkinsonism and Related Disorders, 2021
  • Steroid-Responsive Acute Left-Arm Chorea as a Presenting Symptom of Moyamoya Disease
    Francesco Cavallieri, Marialuisa Zedde, Federica Assenza, Franco Valzania
    Canadian Journal of Neurological Sciences, 2021
  • Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease
    Francesco Cavallieri, Valérie Fraix, Francesco Bove, Delia Mulas, Manuela Tondelli, Anna Castrioto, Paul Krack, Sara Meoni, Emmanuelle Schmitt, Eugénie Lhommée, Amélie Bichon, Pierre Pélissier, Eric Chevrier, Andrea Kistner, Eric Seigneuret, Stephan Chabardès, Elena Moro
    Annals of Neurology, 2021
  • Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
    Francesco Cavallieri, Carla Budriesi, Annalisa Gessani, Sara Contardi, Valentina Fioravanti, Elisa Menozzi, Serge Pinto, Elena Moro, Franco Valzania, Francesca Antonelli
    Frontiers in Neurology, 2021
  • Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)
    Paola Gaviani, Giorgia Simonetti, Roberta Rudà, Federica Franchino, Giuseppe Lombardi, Marco Possanzini, Sara Squintu, Veronica Villani, Mariaausilia Teriaca, Francesco Cavallieri, Maria Caffo, Andrea Salmaggi, Andrea Bianco, Elena Anghileri, Mariangela Farinotti, Irene Tramacere, Antonio Silvani
    Neurological Sciences, 2021
  • Facial palsy during the COVID-19 pandemic
    Luca Codeluppi, Francesco Venturelli, Jessica Rossi, Antonio Fasano, Giulia Toschi, Francesca Pacillo, Francesco Cavallieri, Paolo Giorgi Rossi, Franco Valzania
    Brain and Behavior, 2021
  • Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease
    Francesco Bove, Delia Mulas, Francesco Cavallieri, Anna Castrioto, Stephan Chabardès, Sara Meoni, Emmanuelle Schmitt, Amélie Bichon, Enrico Di Stasio, Andrea Kistner, Pierre Pélissier, Eric Chevrier, Eric Seigneuret, Paul Krack, Valerie Fraix, Elena Moro
    Neurology, 2021
  • EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic
    T. J. von Oertzen, A. Macerollo, M. A. Leone, E. Beghi, M. Crean, S. Oztuk, C. Bassetti, A. Twardzik, D. Bereczki, G. Di Liberto, R. Helbok, C. Oreja‐ Guevara, A. Pisani, A. Sauerbier, J. Sellner, R. Soffietti, M. Zedde, E. Bianchi, B. Bodini, F. Cavallieri, L. Campiglio, L. F. Maia, A. Priori, M. Rakusa, P. Taba, E. Moro, T. M. Jenkins, for the EANcore COVID‐19 task force
    European Journal of Neurology, 2021
  • Extracranial metastases in secondary glioblastoma multiforme: a case report
    Jessica Rossi, Lucia Giaccherini, Francesco Cavallieri, Manuela Napoli, Claudio Moratti, Elisabetta Froio, Silvia Serra, Alessandro Fraternali, Reza Ghadirpour, Salvatore Cozzi, Patrizia Ciammella, Corrado Iaccarino, Rosario Pascarella, Franco Valzania, Anna Pisanello
    BMC Neurology, 2020
  • COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management
    Pedro Fraiman, Clecio Godeiro Junior, Elena Moro, Francesco Cavallieri, Marialuisa Zedde
    Frontiers in Neurology, 2020
  • Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association.
    Francesco Cavallieri, Alessandro Marti, Antonio Fasano, Annalisa Dalla Salda, Angelo Ghirarduzzi, Claudio Moratti, Lara Bonacini, Reza Ghadirpour, Rosario Pascarella, Franco Valzania, Marialuisa Zedde
    Eneurologicalsci, 2020
  • Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19
    Maryam Jalessi, Mitra Barati, Mohammad Rohani, Elahe Amini, Anis Ourang, Zahra Azad, Farideh Hosseinzadeh, Francesco Cavallieri, Reza Ghadirpour, Franco Valzania, Corrado Iaccarino, Arman Ahmadzadeh, Mohammad Farhadi
    Neurological Sciences, 2020
  • The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection
    E. Moro, A. Priori, E. Beghi, R. Helbok, L. Campiglio, C. L. Bassetti, E. Bianchi, L. F. Maia, S. Ozturk, F. Cavallieri, M. Zedde, J. Sellner, D. Bereczki, M. Rakusa, G. Di Liberto, A. Sauerbier, A. Pisani, A. Macerollo, R. Soffietti, P. Taba, M. Crean, A. Twardzik, C. Oreja‐Guevara, B. Bodini, T. M. Jenkins, T. J. von Oertzen, for the EAN core COVID‐19 Task Force
    European Journal of Neurology, 2020
  • Dementia and subthalamic deep brain stimulation in Parkinson disease: A long-term overview
    Francesco Bove, Valerie Fraix, Francesco Cavallieri, Emmanuelle Schmitt, Eugénie Lhommée, Amélie Bichon, Sara Meoni, Pierre Pélissier, Andrea Kistner, Eric Chevrier, Claire Ardouin, Patricia Limousin, Paul Krack, Alim Louis Benabid, Stephan Chabardès, Eric Seigneuret, Anna Castrioto, Elena Moro
    Neurology, 2020
  • First motor seizure as presenting symptom of SARS-CoV-2 infection
    Antonio Fasano, Francesco Cavallieri, Elena Canali, Franco Valzania
    Neurological Sciences, 2020
  • Idiopathic brain calcification in a patient with hereditary hemochromatosis
    Stefania Scarlini, Francesco Cavallieri, Massimo Fiorini, Elisa Menozzi, Francesca Ferrara, Francesca Cavalleri, Chiara Reale, Barbara Garavaglia, Antonello Pietrangelo, Franco Valzania, Elena Corradini
    BMC Neurology, 2020
  • Acute lethargy after abrupt apomorphine withdrawal in Parkinson's disease
    Francesco Cavallieri, Valérie Fraix, Sara Meoni, Paul Krack, Elena Moro, Anna Castrioto
    Journal of the Neurological Sciences, 2019
  • Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12
    Jessica Rossi, Francesco Cavallieri, Giada Giovannini, Carla Budriesi, Annalisa Gessani, Miryam Carecchio, Daniela Di Bella, Elisa Sarto, Jessica Mandrioli, Sara Contardi, Stefano Meletti
    Neurogenetics, 2019
  • Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome
    Annalisa Gessani, Francesco Cavallieri, Carla Budriesi, Elisabetta Zucchi, Marcella Malagoli, Sara Contardi, Maria Teresa Mascia, Giada Giovannini, Jessica Mandrioli
    Neurology, 2019
  • Cervical dystonia in a case of longstanding secondary progressive multiple sclerosis
    F. Cavallieri, C. Godeiro, J.C. Lino Jr, E. Moro
    Revue Neurologique, 2019
  • A case of peripherally induced task-specific “lipstick dystonic tremor”
    Francesco Cavallieri, Franco Valzania, Laurent Vercueil, Elena Moro, Valérie Fraix
    Tremor and Other Hyperkinetic Movements, 2019
  • Identification of dynamic behaviour of forearm for active control of pathological tremor
    Proceedings of the 26th International Congress on Sound and Vibration Icsv 2019, 2019
  • Condition monitoring of parkinson pathological tremor for functional electrical stimulation control
    Antonio Zippo, Francesco Pellicanò, Giovanni Iarriccio, Franco Valzania, Francesco Cavallieri
    16th International Conference on Condition Monitoring and Asset Management CM 2019, 2019
  • Something that touches your heart: an unusual case of abdominal clonic movements
    Valentina Fioravanti, Igor Lamberti, Nicola Bottoni, Francesco Cavallieri, Franco Valzania, Matteo Pugnaghi
    Tremor and Other Hyperkinetic Movements, 2019
  • Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria
    Elisabetta Zucchi, Francesco Cavallieri, Giada Giovannini, Francesca Antonelli, Maria Teresa Mascia, Roberta Bedin, Jessica Mandrioli
    Journal of Clinical Neuroscience, 2018
  • Central pontine myelinolysis and poorly controlled diabetes: MRI’s hints for pathogenesis
    Antonio Fasano, Francesco Cavallieri, Jessica Mandrioli, Annalisa Chiari, Paolo Nichelli
    Neurological Sciences, 2018
  • Something that Touches your Heart: an Unusual Case of Abdominal Clonic Movements
    Valentina Fioravanti, Igor Lamberti, Nicola Bottoni, Francesco Cavallieri, Franco Valzania, et al.
    Tremor and Other Hyperkinetic Movements New York N Y, 2018
  • C9ORF72 and parkinsonism: Weak link, innocent bystander, or central player in neurodegeneration?
    Francesco Cavallieri, Jessica Mandrioli, Francesca Rosafio, Sara Contardi, Antonio Fasano, Elisa Menozzi, Claudia Caponnetto, Adriano Chiò, Franco Valzania
    Journal of the Neurological Sciences, 2017
  • Subacute copper-deficiency myelopathy in a patient with occult celiac disease
    Francesco Cavallieri, Nicola Fini, Sara Contardi, Massimo Fiorini, Elena Corradini, Franco Valzania
    Journal of Spinal Cord Medicine, 2017
  • Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?
    Silvia de Pasqua, Francesco Cavallieri, Roberto D’Angelo, Fabrizio Salvi, Nicola Fini, Roberto D’Alessandro, Rita Rinaldi, Antonio Fasano, Jessica Mandrioli
    Neurological Sciences, 2017
  • Acute hemichorea as unusual first multiple sclerosis presentation
    Giada Giovannini, Francesco Cavallieri, Stefano Meletti, Annalisa Chiari, Jessica Mandrioli, Diana Ferraro, Franco Valzania
    Neurology Clinical Practice, 2017
  • Usefulness of Thromboelastography in the Detection and Management of Tissue Plasminogen Activator-Associated Hyperfibrinolysis
    Francesca Rosafio, Laura Vandelli, Guido Bigliardi, Francesco Cavallieri, Maria Luisa Dell'Acqua, Livio Picchetto, Andrea Zini
    Journal of Stroke and Cerebrovascular Diseases, 2017
  • The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease
    Francesca Rosafio, Francesco Cavallieri, Pietro Guaraldi, Franco Taroni, Paolo Frigio Nichelli, Jessica Mandrioli
    Clinical Neurology and Neurosurgery, 2016
  • MRI correlates of Parkinson's disease progression: A voxel based morphometry study
    Valentina Fioravanti, Francesca Benuzzi, Luca Codeluppi, Sara Contardi, Francesco Cavallieri, Paolo Nichelli, Franco Valzania
    Parkinson S Disease, 2015
  • Pearls & Oy-sters: Rapidly progressive dementia
    Francesco Cavallieri, Jessica Mandrioli, Manuela Tondelli, Francesca Vitetta, Carlotta Stipa, Stefano Vallone, Eleni Georgoulopoulou, Filippo Barbi, Rocco Liguori, Piero Parchi, Paolo Nichelli
    Neurology, 2014
  • Cortical action myoclonus due to cortical laminar necrosis
    Francesco Cavallieri, Valentina Fioravanti, Sara Contardi, Luca Codeluppi, Franco Valzania
    Neurological Sciences, 2014